Ro

Ro

Early Stage

Your healthcare, simplified.

Your healthcare, simplified.

Overview

Funding data not publicly available
Platform

OurCrowd

Start Date

05/02/2020

Close Date

05/13/2020

Min. Goal
$10,000
Max. Goal
$560,000
Min. Investment

$10,000

Security Type

Equity - Common

SEC Filing Type

RegD 506(c)

Year Founded

2017

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Location

New York, New York

Ro is raising funds on OurCrowd through Reg D 506(c) raise. It is a vertically integrated online pharmacy and telehealth company. The platform simplifies healthcare and takes embarrassment off of people dealing with issues related to men’s health, women’s health, and addiction. Additionally, the online pharmacy division of Ro ships and delivers FDA-approved medications discreetly to patients’ doors. Zachariah Reitano, Saman Rahmanian, and Rob Schutz founded Ro in 2017. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $560,000. The campaign proceeds will be used for growth and expansion.
Create a free account today to gain access to KingsCrowd analytics.

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Ro on OurCrowd 2020
Platform: OurCrowd
Security Type: Equity - Common

Follow company

Follow Ro on OurCrowd 2020

Buy Ro's Deal Report

Warning: according to the close date for this deal, Ro may no longer be accepting investments.

Ro Deal Report

Get KingsCrowd’s comprehensive report on Ro including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Ro is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Ro deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge